House
File
2413
H-8103
Amend
House
File
2413
as
follows:
1
1.
Page
1,
before
line
1
by
inserting:
2
<
DIVISION
I
3
CONTROLLED
SUBSTANCES
>
4
2.
Page
6,
after
line
26
by
inserting:
5
<
DIVISION
II
6
DRUG
PARAPHERNALIA
AND
SYRINGE
SERVICES
PROGRAM
7
Sec.
___.
Section
124.414,
subsection
1,
paragraph
b,
Code
8
2020,
is
amended
to
read
as
follows:
9
b.
“Drug
paraphernalia”
does
not
include
hypodermic
needles
10
or
syringes
if
manufactured,
delivered,
sold,
or
possessed
for
11
a
lawful
purpose.
“Lawful
purpose”
includes
hypodermic
needles
12
or
syringes
delivered,
sold,
or
possessed
through
an
approved
13
syringe
services
program
established
pursuant
to
rules
adopted
14
by
the
department
of
public
health.
15
Sec.
___.
Section
135.19,
Code
2020,
is
amended
by
adding
16
the
following
new
subsection:
17
NEW
SUBSECTION
.
3.
The
department
shall
establish
and
18
implement
a
syringe
services
program
for
persons
who
unlawfully
19
inject
controlled
substances
and
who
are
at
an
increased
risk
20
for
exposure
to
hepatitis
B
or
hepatitis
C.
The
program
21
shall
include
hepatitis
C
testing,
referrals
for
treatment
22
of
substance
use
disorders,
and
training
for
opioid
overdose
23
prevention
and
reversal.
24
Sec.
___.
Section
141A.3,
subsection
2,
Code
2020,
is
25
amended
by
adding
the
following
new
paragraph:
26
NEW
PARAGRAPH
.
g.
Establish
and
implement
a
syringe
27
services
program
for
persons
who
unlawfully
inject
controlled
28
substances
and
who
are
at
risk
of
HIV
infection.
The
program
29
shall
include
testing
for
HIV
infection,
referrals
for
30
treatment
of
substance
use
disorders,
and
training
in
opioid
31
overdose
prevention
and
reversal.
32
DIVISION
III
33
EFFECTIVE
DATE
>
34
3.
Title
page,
line
1,
after
<
substances
>
by
inserting
<
and
35
-1-
HF2413.3591
(2)
88
ss/rh
1/
2
#1.
#2.
drug
paraphernalia
>
1
4.
Title
page,
line
3,
after
<
marijuana,
>
by
inserting
2
<
establishing
a
syringe
services
program,
>
3
5.
By
renumbering
as
necessary.
4
______________________________
ISENHART
of
Dubuque
-2-
HF2413.3591
(2)
88
ss/rh
2/
2
#4.
#5.